Recursion Pharmaceuticals, Inc. (RXRX)
3.98
+0.42
(+11.80%)
USD |
NASDAQ |
Feb 06, 16:00
3.97
-0.01
(-0.25%)
After-Hours: 20:00
Recursion Pharmaceuticals SG&A Expense (TTM) : 220.12M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| XOMA Royalty Corp. | 32.68M |
| Mirum Pharmaceuticals, Inc. | 239.73M |
| Hims & Hers Health, Inc. | 1.147B |
| Plus Therapeutics, Inc. | 11.09M |